Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Titel:
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Auteur:
De Jaeghere, Emiel A. Tuyaerts, Sandra Van Nufel, An M. T. Belmans, Ann Bogaerts, Kris Baiden-Amissah, Regina Lippens, Lien Vuylsteke, Peter Henry, Stéphanie Trinh, Xuan Bich van Dam, Peter A. Aspeslagh, Sandrine De Caluwé, Alex Naert, Eline Lambrechts, Diether Hendrix, An De Wever, Olivier Van de Vijver, Koen K. Amant, Frédéric Vandecasteele, Katrien Denys, Hannelore G.